Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04577443
Other study ID # Adenosine H-20027630
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2020
Est. completion date October 30, 2021

Study information

Verified date November 2022
Source Danish Headache Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Adenosine is a nucleoside that plays a role in both vascular and nociceptive systems, and it has been proposed that adenosine may cause headache in particularly sensitive subjects. Thus, considerable evidence implied that adenosine plays a role in migraine pathophysiology, it is still unknown if intravenous adenosine infusion provokes migraine attacks in healthy subject or in migraine patients. Furthermore, adenosine's effects on the cerebral hemodynamic remains unknown. This study aims to clarify a possible coherence between adenosine and headache/migraine. In general, the study will contribute to a greater understanding of migraine pathogenesis and possibly lead to development of specific migraine treatment.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date October 30, 2021
Est. primary completion date October 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Migraine patients without aura who fulfill criteria in the international classification of headaches. This does not apply to healthy volunteers. - 18-60 years. - 50-90 kg. - Women of childbearing potential must use adequate contraception Exclusion Criteria: - Headache less than 48 hours before the tests start - All primary headaches, except migraine without aura for migraine patients, according to international classification of headache - Daily consumption of drugs of any kind other than oral contraceptives - Pregnant or nursing women. - Cardiovascular disease of any kind, including cerebrovascular diseases.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Adenosine
To investigate the role of adenosine on cerebral hemodynamic and headache in healthy volunteers and migraine patients
Saline
To investigate the role of saline on cerebral hemodynamic and headache in healthy volunteers and migraine patients

Locations

Country Name City State
Denmark Rigshospitalet-Glostrup Glostrup Nordre Ringvej 57

Sponsors (1)

Lead Sponsor Collaborator
Danish Headache Center

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Occurrence and change of migraine attack Occurrence and of migraine according to international criteria Before (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of saline
Secondary Change in cerebral hemodynamic Change on velocity of media cerebri artery. Before (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of saline
Secondary Occurrence and change of headache Occurrence of headache measured by numerical rating scale (NRS) Before (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of saline
Secondary Change of diameter of the artery Change of diameter of superficial temporal artery and radial artery. The diameter will be measured by millimeter (mm). Before (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of saline
See also
  Status Clinical Trial Phase
Recruiting NCT05503082 - Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies Phase 4
Completed NCT04905654 - Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura N/A
Completed NCT04111484 - Adrenomedullin Effect on Migraine Without Patients N/A
Recruiting NCT04091789 - Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea Phase 2
Completed NCT03337620 - Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine Phase 3
Completed NCT02259387 - Adolescents With Migraine: What's Stress Got To Do With It?
Completed NCT05658185 - Migraine Difficult to Treat: the Importance of Psychological Care in the Chronic Patient N/A
Completed NCT05001399 - Feasibility of Using Holographic Memory Resolution® (HMR) in Patients/Clients With Pain N/A
Completed NCT03490500 - Using the S100B Protein for Emergency Headache Management Care (S100)
Completed NCT03075020 - Carbon Monoxide Migraine-inducing Effects in Patients With Migraine Without Aura. N/A
Recruiting NCT03472092 - Mind and Body Approaches to Pain Reduction in Youth With Migraine Phase 2
Enrolling by invitation NCT04976985 - Osteopathic Manipulative Treatment and Migraine Headaches N/A
Active, not recruiting NCT04372264 - Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache Phase 4
Recruiting NCT04623203 - The Prognosis of Migraine and Tension-Type Headache in Children and Adolescents
Completed NCT03560024 - The Effect of PACAP27 on the Extra- and Intracerebral Arteries Assessed by Magnetic Resonance Angiography (MRA) on Healthy Volunteers N/A
Completed NCT03228355 - Headache Inducing Effect of Cromakalim in Migraine Patients N/A
Completed NCT02438553 - Short-term Effectiveness of Transcutaneous Nerve Stimulation in Reducing Migraine Related Pain N/A
Recruiting NCT03577548 - Influence of Main Psychological and Social Factors on Primary Headaches
Recruiting NCT04715685 - Mind Body Balance for Pediatric Migraine N/A
Completed NCT05853900 - Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Phase 3